It’s available as the brand-name drug Eliquis. The cost of apixaban, with and without insurance, can depend on several factors, such as whether the drug has a savings program. As with all ...

Bristol Myers Squibb Co. raised its 2024 earnings guidance after reporting better-than-expected revenue and profit, fueled by demand for the blood-thinner Eliquis and several newer treatments.Adjusted ...

Lawyers for AstraZeneca , Bristol Myers Squibb and Johnson & Johnson's Janssen on Wednesday urged a federal appeals court in ...

Bristol Myers Squibb reported third-quarter earnings and revenue that blew past expectations on strong sales from its blood thinner Eliquis and a portfolio of drugs it expects to deliver long-term ...

After many months of closely watched negotiations, the Centers for Medicare & Medicaid Services (CMS) announced the list of negotiated prices for 10 drugs. This marks the first set of negotiations ...

It continued: "The IRA does not protect patients from potential increases to their cost sharing or restrictions in access to Eliquis once the MFP goes into effect in January 2026. By focusing on ...

Bristol Myers Squibb's revenue was fueled by Growth Portfolio and Eliquis. Analysts anticipate an impact from Cobenfy and a ...

The first session, on Eliquis, is set for Oct. 30 ... was signed into law last year allows Medicare to directly negotiate prices of certain high-expenditure, single-source drugs without generic ...

This forces pharmacies to lose money, especially on brands like Ozempic, Paxlovid and Eliquis. If pharmacies ... This steers patients to higher-cost medications and boosts PBM profits.

Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action.

The U.S. drugmaker is turning to deals at a time when two of its top drugs, blood cancer treatment Revlimid and blood thinner Eliquis ... for reducing the high cost of prescription drugs, and ...